Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it’s not accessible to everyone.
OLYMPIA, Wash. — Scientists have developed a new way to use information from your genes or proteins to help doctors diagnose or treat diseases.
This method, known as biomarker testing, has the potential to improve patient outcomes significantly, but its high cost means it’s not accessible to everyone.
House Bill 1062 aims to change that, requiring private and public insurance companies to cover biomarker testing. For patients like Kaelyn Lukson, it’s been life-changing.
At 49, the mother of two from Shoreline was
→ Continue reading at King 5
